The American College of Rheumatology response criteria for proliferative and membranous renal disease in systemic lupus erythematosus clinical trials.
D000569:Americas; D002986:Clinical Trials as Topic; D023381:Endpoint Determination / Q000379:methods*; D006801:Humans; D008181:Lupus Nephritis / Q000175:diagnosis / Q000188:drug therapy* / Q000503:physiopathology; D016239:MEDLINE; D012219:Rheumatology / Q000379:methods*; D012955:Societies, Medical; D016896:Treatment Outcome